Preterm children are among the most vulnerable patients in modern clinical care. Their bodies are underdeveloped and they are in an extremely fragile condition. A very important role is played by the oxygen supply to the brain: When there is an under- or even oversupply of oxygen, these children face the threat of life-long damages or immediate death. Worst of all, this can not be observed from the outside, which is a terrible situation for the medical staff and for the parents, let alone for the babies themselves. OxyPrem is a new sensor which uses harmless light to show the oxygen situation in the preterm brain. It gets placed onto the head of the baby and notifies doctors when oxygen levels move outside the normal range. Then, easy and effective countermeasures can be taken.

News

Milestones/News

06.06.2024 Design Freeze for new sensor
01.08.2022 OxyPrem now ISO 13485 certified
01.08.2022 OxyPrem in Swiss Excellence Award finals
01.01.2022 OxyPrem obtains CHF 2.2 million grant
01.11.2020 OxyPrem wins another Seal of Excellence
01.05.2020 OxyPrem wins EU Seal of Excellence
01.09.2019 OxyPrem 1.4 gets CE mark
01.09.2019 OxyPrem obtains EU support
01.08.2019 OxyPrem wins Venture Kick
01.05.2019 OxyPrem enters Innosuisse Core Coaching
01.04.2019 OxyPrem wins Swiss Indian AIT award
01.02.2019 OxyPrem enters Wyss Zurich
01.12.2018 Uniscientia supports UZH and OxyPrem
01.11.2018 OxyPrem moves on in Venture Kick
01.08.2018 OxyPrem gets venture kicked
01.02.2018 OxyPrem team obtains UZH BioEntrepreneur Fellowship
01.02.2018 Cooperation with Therapy Development Accelerator